Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Sci Transl Med. 2018 Apr 11;10(436):eaan8292. doi: 10.1126/scitranslmed.aan8292

Table 1:

Comparison of incidence of venous thrombosis between groups according to the presence of CHIP and JAK2V617F mutation.

Analysis groups *# Control P value $ Schizophrenia P value$ All P value$
Non-CHIP vs. CHIP 0.0006 (0.003) 0.11 0.0004 (0.002)
Non-CHIP vs. Non-JAK2V617F CHIP 0.008 (0.04) 0.57 0.025 (0.125)
Non-CHIP vs. JAK2V617F CHIP 0.0009 (0.0045) 0.12 0.0003 (0.0015)
*

Individuals with <3 mutations of unknown significance were excluded from further analysis. Individuals with ≥3 mutations of unknown significance are classified as having clonal hematopoiesis with unknown driver (see also table S5).

#

Rates of thrombosis compared between groups by Fisher’s exact test

$

Nominal P values are given first. Adjusted P values after Bonferroni correction are given in parentheses.